These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

315 related items for PubMed ID: 32278455

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. AERD Associated Nasal Polyposis: Efficacy of Postoperative Antileukotriene Therapy in Comparison with Aspirin Desensitization. A Retrospective Study.
    San Nicoló M, Habermann N, Havel M.
    Int Arch Allergy Immunol; 2020; 181(10):790-798. PubMed ID: 32777782
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mepolizumab targets multiple immune cells in aspirin-exacerbated respiratory disease.
    Buchheit KM, Lewis E, Gakpo D, Hacker J, Sohail A, Taliaferro F, Berreondo Giron E, Asare C, Vukovic M, Bensko JC, Dwyer DF, Shalek AK, Ordovas-Montanes J, Laidlaw TM.
    J Allergy Clin Immunol; 2021 Aug; 148(2):574-584. PubMed ID: 34144111
    [Abstract] [Full Text] [Related]

  • 8. New concepts for the pathogenesis and management of aspirin-exacerbated respiratory disease.
    Sehanobish E, Asad M, Jerschow E.
    Curr Opin Allergy Clin Immunol; 2022 Feb 01; 22(1):42-48. PubMed ID: 34739410
    [Abstract] [Full Text] [Related]

  • 9. Aspirin exacerbated respiratory disease: Current topics and trends.
    Rodríguez-Jiménez JC, Moreno-Paz FJ, Terán LM, Guaní-Guerra E.
    Respir Med; 2018 Feb 01; 135():62-75. PubMed ID: 29414455
    [Abstract] [Full Text] [Related]

  • 10. Certain subphenotypes of aspirin-exacerbated respiratory disease distinguished by latent class analysis.
    Bochenek G, Kuschill-Dziurda J, Szafraniec K, Plutecka H, Szczeklik A, Nizankowska-Mogilnicka E.
    J Allergy Clin Immunol; 2014 Jan 01; 133(1):98-103.e1-6. PubMed ID: 23993879
    [Abstract] [Full Text] [Related]

  • 11. Aspirin-Exacerbated Respiratory Disease and the Unified Airway: A Contemporary Review.
    Walters BK, Hagan JB, Divekar RD, Willson TJ, Stokken JK, Pinheiro-Neto CD, O'Brien EK, Choby G.
    Otolaryngol Clin North Am; 2023 Feb 01; 56(1):107-124. PubMed ID: 36283868
    [Abstract] [Full Text] [Related]

  • 12. Steroids Inhibit Eosinophil Accumulation and Downregulate Hematopoietic Chemotaxic Prostaglandin D2 Receptor in Aspirin-Exacerbated Respiratory Disease.
    Suzuki N, Ko-Mitamura EP, Inui T, Terada T, Dejima K, Nagata N, Urade Y, Kawata R.
    Ear Nose Throat J; 2021 Sep 01; 100(5_suppl):738S-745S. PubMed ID: 32077309
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Survey-Defined Patient Experiences With Aspirin-Exacerbated Respiratory Disease.
    Ta V, White AA.
    J Allergy Clin Immunol Pract; 2015 Sep 01; 3(5):711-8. PubMed ID: 25858054
    [Abstract] [Full Text] [Related]

  • 17. Thymic stromal lymphopoietin controls prostaglandin D2 generation in patients with aspirin-exacerbated respiratory disease.
    Buchheit KM, Cahill KN, Katz HR, Murphy KC, Feng C, Lee-Sarwar K, Lai J, Bhattacharyya N, Israel E, Boyce JA, Laidlaw TM.
    J Allergy Clin Immunol; 2016 May 01; 137(5):1566-1576.e5. PubMed ID: 26691435
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.